• Hi Guest: Welcome to TRIBE, the online home of TRIBE MAGAZINE. If you'd like to post here, or reply to existing posts on TRIBE, you first have to register. Join us!

Nobody Cares...

RumRogerz

TRIBE Member
If I have a zipper that won't zip up anymore (teeth won't connect) can I take this shit in somewhere or am I accepting fate and tossing this shit?

I really don't want to; I'm a piss broke student
 
tribe cannabis accessories silver grinders

[- FuNKtiOn -]

TRIBE Member
Ditto on the cancer free high five.


On the topic of zippers, they easily replaceable but the size of the zipper and what its attached to will dramatically vary the cost. For example, a single layer spring jacket or hoodie should cost no more than $20 to replace (zipper and labour cost), but if there are multiple layers of fabric and a potential fill in between, that price could double quickly.
 
tribe cannabis accessories silver grinders
tribe cannabis accessories silver grinders

basketballjones

TRIBE Member
Yes and thank you... Hope that will be the end of it...The only good thing about the chemi was not having to shave...
congrats!!
did you get a full mri done or just a partial?

reason i ask is last year at this time my mom was doing chemo for cancer and was declared cancer free. in the summer she started to deterioate and they finally did a full mri and found 9 spots of cancer on her brain and in her lungs(she had been to her dr 19 times saying she was noticing things with her health but her dr thought she was just being a complainer)

they only checked where they were focusing on to save money im guessing

either way to find so much cancer after being declared cancer free is ridiculous

really wouldnt matter much with the cancer in her brain as its inoperable and ultimately terminal. though if they got to it those months earlier they could have started treatment earlier to make her quality of life that much better.
 

cosmosuave

TRIBE Member
Thanks everyone...

As for BBJ no mri just a CT scan of the thorax abdomen and pelvis... Treatment was for seminoma on the left lung... Prior to that it was an orchioectomy then radiation then the chemo... As I was told nut cancer was the best to get well it has been a fucker to get rid of... If I can get another 20 years outta me I will be happy....

Once again apreciate all the thanks... Means a lot...
 
tribe cannabis accessories silver grinders

basketballjones

TRIBE Member
i would be all over your dr's in continually getting checked. cancer spreads like a mother fucker and to all manner of places. my moms lungs and brain were not even on this planets radar or as an option when they declared my mom cancer free

still, great to hear just in time for xmas!
 

wickedken

TRIBE Member
Thanks everyone...

As for BBJ no mri just a CT scan of the thorax abdomen and pelvis... Treatment was for seminoma on the left lung... Prior to that it was an orchioectomy then radiation then the chemo... As I was told nut cancer was the best to get well it has been a fucker to get rid of... If I can get another 20 years outta me I will be happy....

Once again apreciate all the thanks... Means a lot...
Good stuff!
 

Bernnie Federko

TRIBE Member
Business





Martin Shkreli, who hiked price of life-saving pill Daraprim, arrested for securities fraud
Man dubbed ‘America’s most hated man’ whom even Donald Trump called a ‘spoiled brat’ is alleged to have made secret payoffs and set up sham consulting arrangements.
RICHARD PERRY / NYT
Martin Shkreli, 32, ignited a firestorm over drug prices in September and became a symbol of defiant greed.
Published on Dec 17 2015
Bloomberg
A boyish drug company entrepreneur, who rocketed to infamy by jacking up the price of a life-saving pill from $13.50 to $750, was arrested at his Manhattan home early Thursday morning on securities fraud related to a firm he founded.
Martin Shkreli, 32, ignited a firestorm over drug prices in September and became a symbol of defiant greed. The federal case against him has nothing to do with pharmaceutical costs, however. Prosecutors charged him with illegally taking stock from Retrophin Inc., a biotechnology firm he started in 2011, and using it pay off debts from unrelated business dealings. He was later ousted from the company, where he’d been chief executive officer, and sued by its board.
In the case that closely tracks that suit, federal prosecutors accused Shkreli of engaging in a complicated shell game after his defunct hedge fund, MSMB Capital Management, lost millions. He is alleged to have made secret payoffs and set up sham consulting arrangements. A New York lawyer, Evan Greebel, was also arrested early Thursday. He’s accused of conspiring with Shkreli in part of the scheme.
Shkreli’s lawyer and spokesmen for Retrophin, KaloBios and Turing didn’t immediately respond to requests for comment. Greebel and his firm weren’t immediately available to comment either.
KaloBios Pharmaceuticals Inc. plummeted 50 per cent Thursday in early trading after the arrest.
Shkreli bought a majority interest in KaloBios last month and named himself CEO. The company’s stock was trading at less than $1 before he made the move, and the stock subsequently rose to as high as $39.50, giving the company a market value of more than $100 million.
KaloBios shares fell 50 percent to $11.75 in New York trading before the market opened. Trading in the stock was halted as of 6:48 a.m.
Shkreli’s extraordinary history — and current hold on the public imagination — makes the case more noteworthy than most involving securities fraud. The son of immigrants from Albania and Croatia who worked as janitors and raised him deep in working-class Brooklyn, Shkreli both epitomizes the American dream and sullies it. As a youth, he showed exceptional promise and independence and, after dropping out of an elite Manhattan high school, began his conquest of Wall Street before he was 20.
His name entered public consciousness after he raised the price more than 55-fold for Daraprim. It is the preferred treatment for a parasitic condition known as toxoplasmosis, which can be deadly for unborn babies and patients with compromised immune systems including those with HIV or cancer. His company, Turing Pharmaceuticals AG, bought the drug, moved it to a closed distribution system and instantly drove the price into the stratosphere.
The moves drew shocked rebukes from Congress, public-interest groups, doctors and presidential candidates, and cast an unwelcome spotlight on the rising prices of older drugs. Donald Trump called Shkreli a “spoiled brat,” and the BBC dubbed him the “most hated man in America.” Bernie Sanders, a Democratic presidential candidate, rejected a $2,700 campaign donation from him, directing it to an HIV clinic. A spokesman said in October that the campaign would not keep money “from this poster boy for drug company greed.”
Shkreli initially responded to the criticism by saying he would lower the Daraprim price and then changed his mind again. When Hillary Clinton tried one more time last month to get him to cut the cost, he dismissed her with the tweet “lol.” At a Forbes summit in New York this month, wearing a hooded sweatshirt, he said if he could have done it over, “I probably would have raised the price higher,” adding, “my investors expect me to maximize profits.”
In fact, it is not only his drug pricing that has turned him into an object of public derision. He recently spent millions on the only copy of a Wu-Tang Clan album that music fans would love to hear and then told Bloomberg Businessweek that he had no immediate plans to listen to it. He spars often on Twitter and message boards, parading his business strategies, musical tastes and politics; he live-streams from his office for long stretches.
And a range of investors has been after him for some time.
Retrophin sued Shkreli in August for misuse of company funds, claiming he engineered numerous transactions between investors in MSMB and the biotechnology firm. Similar allegations are laid out in the company’s regulatory filings.
The company alleged in a complaint filed in Manhattan federal court that, through a disastrous trade with Merrill Lynch in 2011, Shkreli cost MSMB more than $7 million, leaving it virtually bankrupt.
The Securities and Exchange Commission, which according to court documents opened an investigation into Shkreli in 2012, is expected to file a parallel civil complaint against him, according to people familiar with the matter.
Shkreli spoke cavalierly of the company’s lawsuit, saying, “The $65 million Retrophin wants from me would not dent me. I feel great. I’m licking my chops over the suits I’m going to file against them.”
 
tribe cannabis goldsmith - gold cannabis accessories
Top